Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CTH | P32929 | 1/20 | 0.33 |
| ▸ | CBS | P35520 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | CD69 | Q07108 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL431399 | 0.83 | — | — | |
| SCHEMBL7682659 | 0.83 | TSHR (0.41) | PAMTSHRSMN1; SMN2CTHCBS | |
| SCHEMBL11989018 | 0.82 | MGAM (0.32) | MAPK1 | |
| SCHEMBL27975146 | 0.80 | TSHR (0.39) | PAMTSHRSMN1; SMN2CTHCBS | |
| SCHEMBL10019280 | 0.80 | MAPK1 (0.42) | SMN1; SMN2MAPK1 | |
| SCHEMBL5607319 | 0.79 | GAA (0.50) | TSHR | |
| SCHEMBL5514801 | 0.76 | NAAA (0.38) | TSHRCHRM1 | |
| SCHEMBL7682664 | 0.75 | ALDH1A1 (0.38) | MAPK1 | |
| SCHEMBL19262297 | 0.74 | CYP2C19 (0.32) | ADRA1ACYP2C19 | |
| SCHEMBL13469586 | 0.73 | PAM (0.48) | PAMTSHRSMN1; SMN2CTHCBS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9011918-B2 | Biocompatible and biodegradable elastomeric polymers | EVONIK CORPORATION (US) | 2015-04-21 | — | — | US | disclosed |
| US-20120301518-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2012-11-29 | — | — | US | disclosed |
| US-8246991-B2 | Biocompatible and biodegradable elastomeric polymers | SURMODICS PHARMACEUTICALS, INC. (US) | 2012-08-21 | — | — | US | disclosed |
| US-20100003305-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120301518-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | ECPAS, FN1, DDR1 | PAM 1159/4885TSHR 3155/4885SMN1; SMN2 1254/4885 |
| US-20100003305-A1 | BIOCOMPATIBLE AND BIODEGRADABLE ELASTOMERIC POLYMERS | ECPAS, FN1, DDR1 | PAM 1159/4885TSHR 3155/4885SMN1; SMN2 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.